Granahan Investment Management, LLC Intellia Therapeutics, Inc. Transaction History

Granahan Investment Management, LLC

  • $2.38 Billion
  • Q3 2024

A detailed history of Granahan Investment Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 283,534 shares of NTLA stock, worth $4.05 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
283,534
Previous 214,910 31.93%
Holding current value
$4.05 Million
Previous $4.81 Million 21.15%
% of portfolio
0.25%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.72 - $27.36 $1.35 Million - $1.88 Million
68,624 Added 31.93%
283,534 $5.83 Million
Q2 2024

Aug 14, 2024
SELL
$20.02 - $27.22 $106,286 - $144,510
-5,309 Reduced 2.41%
214,910 $4.81 Million
Q1 2024

May 15, 2024
SELL
$23.82 - $32.8 $894,965 - $1.23 Million
-37,572 Reduced 14.57%
220,219 $6.06 Million
Q4 2023

Feb 14, 2024
BUY
$23.16 - $32.34 $1.22 Million - $1.7 Million
52,600 Added 25.63%
257,791 $7.86 Million
Q3 2023

Nov 14, 2023
SELL
$31.62 - $45.78 $1.79 Million - $2.59 Million
-56,674 Reduced 21.64%
205,191 $6.49 Million
Q2 2023

Aug 14, 2023
BUY
$34.58 - $46.03 $89,250 - $118,803
2,581 Added 1.0%
261,865 $10.7 Million
Q1 2023

May 15, 2023
BUY
$33.3 - $44.82 $1.39 Million - $1.87 Million
41,661 Added 19.14%
259,284 $9.66 Million
Q4 2022

Feb 14, 2023
BUY
$33.21 - $62.69 $2.22 Million - $4.19 Million
66,788 Added 44.28%
217,623 $7.59 Million
Q3 2022

Nov 14, 2022
SELL
$53.92 - $71.7 $728,459 - $968,667
-13,510 Reduced 8.22%
150,835 $8.44 Million
Q2 2022

Aug 15, 2022
BUY
$38.49 - $76.21 $2.76 Million - $5.47 Million
71,736 Added 77.46%
164,345 $8.51 Million
Q1 2022

May 16, 2022
SELL
$58.27 - $118.99 $1.35 Million - $2.76 Million
-23,174 Reduced 20.02%
92,609 $6.73 Million
Q4 2021

Feb 14, 2022
SELL
$100.76 - $138.36 $7.17 Million - $9.85 Million
-71,202 Reduced 38.08%
115,783 $13.7 Million
Q3 2021

Nov 15, 2021
SELL
$132.37 - $176.78 $5.14 Million - $6.86 Million
-38,818 Reduced 17.19%
186,985 $25.1 Million
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $999,284 - $2.66 Million
16,414 Added 7.84%
225,803 $36.6 Million
Q1 2021

May 17, 2021
BUY
$46.59 - $83.68 $4.06 Million - $7.3 Million
87,246 Added 71.43%
209,389 $16.8 Million
Q4 2020

Feb 12, 2021
BUY
$18.83 - $63.53 $905,892 - $3.06 Million
48,109 Added 64.98%
122,143 $6.65 Million
Q3 2020

Nov 12, 2020
SELL
$17.47 - $24.93 $39,674 - $56,616
-2,271 Reduced 2.98%
74,034 $1.47 Million
Q2 2020

Aug 14, 2020
BUY
$11.14 - $22.87 $188,967 - $387,943
16,963 Added 28.59%
76,305 $1.6 Million
Q1 2020

May 12, 2020
SELL
$9.44 - $15.58 $7,221 - $11,918
-765 Reduced 1.27%
59,342 $726,000
Q4 2019

Feb 14, 2020
BUY
$10.43 - $17.67 $4,338 - $7,350
416 Added 0.7%
60,107 $882,000
Q3 2019

Nov 15, 2019
BUY
$13.07 - $18.51 $59,180 - $83,813
4,528 Added 8.21%
59,691 $797,000
Q2 2019

Aug 14, 2019
SELL
$13.88 - $18.41 $22,166 - $29,400
-1,597 Reduced 2.81%
55,163 $903,000
Q1 2019

May 14, 2019
SELL
$12.79 - $17.62 $52,106 - $71,783
-4,074 Reduced 6.7%
56,760 $969,000
Q4 2018

Feb 13, 2019
SELL
$11.39 - $27.13 $245,169 - $583,973
-21,525 Reduced 26.14%
60,834 $830,000
Q3 2018

Nov 13, 2018
SELL
$25.78 - $32.6 $987,013 - $1.25 Million
-38,286 Reduced 31.73%
82,359 $2.36 Million
Q2 2018

Aug 15, 2018
BUY
$20.02 - $30.79 $204,264 - $314,150
10,203 Added 9.24%
120,645 $3.3 Million
Q1 2018

May 14, 2018
SELL
$19.43 - $34.95 $391,825 - $704,801
-20,166 Reduced 15.44%
110,442 $2.33 Million
Q4 2017

Feb 12, 2018
SELL
$17.39 - $31.12 $2.7 Million - $4.84 Million
-155,536 Reduced 54.36%
130,608 $2.51 Million
Q3 2017

Nov 14, 2017
BUY
$15.16 - $25.75 $4.34 Million - $7.37 Million
286,144
286,144 $7.11 Million

Others Institutions Holding NTLA

# of Institutions
313
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.09B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email